• Analysis and Studies
• Vaccines

One could imagine the growth of the vaccine trade after the first vaccine made available in November 2020, but some of the data reported below may be surprising.

With over $19.6 billion USD in exports, Belgium became the key player in vaccine trade. But China and the US are not too far behind. With nearly $9.4 billion and $4.9 billion in exports respectively, these three countries have become the global leaders in vaccine manufacturing and trade.

Since the approval of the first COVID vaccine in November 2020, vaccine exports have grown 43,000% in China, 3,200% in Spain, 693% in Russia, 601% in the US, and 478% in Belgium. 

Analysing the top export destination, we find that around 46% of Belgium's vaccine exports end in Europe, mainly in Germany ($3.4B) and the UK ($0.8B). But a significant portion of Belgium's vaccine exports has also gone to Asia (30%), especially to Japan ($1.9B). 

China's recent vaccine exports went primarily to Indonesia ($1.16B), Pakistan ($0.73B) and Turkey ($0.56B), whereas the US has also been supplying mostly North America (44%) and South America (30%), with Canada ($1.63B), and Brazil ($0.93B) as top destinations.